The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.

The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.

OBJECTIVES: To describe the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) and changing trends in their use. METHODS: We used the General Practice Research Database (GPRD) to describe DMARD use by patients with RA identified using ICD-9 codes. Th...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Edwards, C, Arden, N, Fisher, D, Saperia, J, Reading, I, Van Staa, T, Cooper, C
Format:	Journal article
Sprog:	English
Udgivet:	2005

Lignende værker

The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from The General Practice Research Database (GPRD) the changing use of disease-modifying anti-rheumatic drugs for RA from The General Practice Research Database
af: Edwards, C, et al.
Udgivet: (2005)

The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from the general practice research database (GPRD).
af: Edwards, C, et al.
Udgivet: (2004)

REGIONAL DIFFERENCES IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
af: Edwards, C, et al.
Udgivet: (2012)

Individual DMARDs have different effects on the likelihood of developing septic arthritis in adults with rheumatoid arthritis
af: Edwards, C, et al.
Udgivet: (2005)

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis.
af: Edwards, C, et al.
Udgivet: (2007)

Myocardial infarction in rheumatoid arthritis: The effects of DMARDs and prednisolone
af: Edwards, C, et al.
Udgivet: (2008)

Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines.
af: Wallace, G, et al.
Udgivet: (2013)

Myocardial infarction in rheumatoid arthritis: The effects of traditional risk factors, anti-hypertensive and lipid-lowering medication
af: Edwards, C, et al.
Udgivet: (2008)

The increased risk of myocardial infarction in patients with rheumatoid arthritis is greatest in young women and is not due to traditional risk factors
af: Arden, N, et al.
Udgivet: (2006)

Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom
af: Judge, A, et al.
Udgivet: (2015)

Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study
af: Edwards, C, et al.
Udgivet: (2012)

TEMPORAL TRENDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN THE UK WITH REFERENCE TO BEST PRACTICE
af: Edwards, C, et al.
Udgivet: (2012)

How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the General Practice Research Database?
af: Thomas, S, et al.
Udgivet: (2007)

How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database?
af: Thomas, S, et al.
Udgivet: (2008)

Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management
af: Sukhbir Singh, et al.
Udgivet: (2024-02-01)

Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
af: Priyam Das, et al.
Udgivet: (2023-06-01)

Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
af: Andrea Giachi, et al.
Udgivet: (2022-10-01)

Early environmental factors and rheumatoid arthritis.
af: Edwards, C, et al.
Udgivet: (2006)

The effects of disease-modifying antirheumatic drugs on dementia in patients with rheumatoid arthritis: a population-based propensity-matched cohort study over 15 years
af: Judge, A, et al.
Udgivet: (2017)

Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
af: Chun-Yu Lin, et al.
Udgivet: (2023-07-01)

Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis
af: Kate Tokareva, et al.
Udgivet: (2025-01-01)

Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
af: Judge, AD, et al.
Udgivet: (2017)

Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom
af: Taylor, PC, et al.
Udgivet: (2021)

Data from the Romanian Registry of Rheumatic Diseases for patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs during 2019
af: Catalin Codreanu, et al.
Udgivet: (2020-03-01)

Neutrophil, monocyte and lymphocyte locomotion in rheumatic fever and rheumatoid arthritis
af: H Ertuğ, et al.
Udgivet: (1990-04-01)

Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
af: Junyu Fan, et al.
Udgivet: (2023-09-01)

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs
af: Iván Arias de la Rosa, et al.
Udgivet: (2021-10-01)

PATIENT EXPECTATIONS OF TREATMENT GOALS AND GOAL-SETTING PRACTICES IN RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
af: Taylor, P, et al.
Udgivet: (2012)

The effect of TNF blockade on insulin resistance in patients with rheumatoid arthritis
af: Edwards, C, et al.
Udgivet: (2006)

Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases
af: Elena Rezus, et al.
Udgivet: (2023-09-01)

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
af: van Staa, T, et al.
Udgivet: (2006)

THU0108 Patient reported outcome measures following knee and hip replacement for individuals with rheumatoid arthritis: evidence from routinely-collected data
af: Burn, E, et al.
Udgivet: (2018)

South African Rheumatism and Arthritis Association 2024 updated guidelines for the management of rheumatoid arthritis
af: G Tarr, et al.
Udgivet: (2024-09-01)

Impact of biologic therapies on need for hip and knee replacement among rheumatoid arthritis and non-rheumatoid arthritis patients in Ontario, Canada: An interrupted time-series analysis
af: Hawley, S, et al.
Udgivet: (2017)

Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
af: Benjamin Birkner, et al.
Udgivet: (2020-01-01)

Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs
af: Hiroki Tawaratsumida, et al.
Udgivet: (2017-12-01)

Biosimilars in rheumatoid arthritis in 2022 – data from the Romanian Registry of Rheumatic Diseases
af: Horatiu Popoviciu, et al.
Udgivet: (2023-09-01)

Doppler US in rheumatic diseases with special emphasis on rheumatoid arthritis and spondyloarthritis
af: Hüseyin Toprak, et al.
Udgivet: (2014-01-01)

Periodontal Condition in Patients with Rheumatoid Arthritis: Effect of Anti-rheumatic Drugs
af: Samira Kordtabar, et al.
Udgivet: (2019-09-01)

CONTROL OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY IS NOT SUMMARISED BY ESR ALONE
af: Dennison, E, et al.
Udgivet: (2003)